Screener
Coherus BioSciences CHRS Q3 2025 earnings
Reported November 6, 2025 · After market close
Revenue$11.6MMiss by $2.5M
EPS-$0.33Miss by $0.01
Revenue estimate$14.1M
EPS estimate-$0.32
Next report
Nov 5, 2026 (in 2 months)Revenue estimate$16.0M
EPS estimate-$0.21
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Coherus BioSciences report Q3 2025 earnings?
- Coherus BioSciences (CHRS) reported Q3 2025 earnings on November 6, 2025 after market close.
- What were Coherus BioSciences's Q3 2025 revenue and EPS?
- Coherus BioSciences reported revenue of $11.6M and eps of $-0.33 for Q3 2025.
- Did Coherus BioSciences beat estimates in Q3 2025?
- Revenue missed the consensus estimate of $14.1M by $2.5M. EPS missed the consensus estimate of $-0.32 by $0.01.
- How did Coherus BioSciences's Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 83.7% from $70.8M a year earlier and eps declined 3200.0% from $-0.01.
- Where can I find Coherus BioSciences's Q3 2025 SEC filings?
- You can read the 8-K earnings release (0001104659-25-107780) and the 10-Q periodic report (0001104659-25-107852) directly on SEC EDGAR. The filing index links above go to sec.gov.
